KRT-232, a first-in-class, murine double minute 2 inhibitor (MDM2i), for TP53 wild-type (p53(WT)) Merkel cell carcinoma (MCC) after anti-PD-1/L1 immunotherapy Meeting Abstract
| Authors: | Wong, M. K. K.; Kelly, C. M.; Burgess, M. A.; Lewis, K.; Grewal, J. S.; Olszanski, A. J.; McGreivy, J.; Rothbaum, W.; Qamoos, H.; DeCaprio, J. A. |
| Abstract Title: | KRT-232, a first-in-class, murine double minute 2 inhibitor (MDM2i), for TP53 wild-type (p53(WT)) Merkel cell carcinoma (MCC) after anti-PD-1/L1 immunotherapy |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368300175 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.10072 |
| Notes: | Meeting Abstract: 10072 -- Source: Wos |
